This company has been marked as potentially delisted and may not be actively trading. Accelerant (ARX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock ARX vs. DLB, LFUS, VSH, ROG, APH, and GLWShould you be buying Accelerant stock or one of its competitors? The main competitors of Accelerant include Dolby Laboratories (DLB), Littelfuse (LFUS), Vishay Intertechnology (VSH), Rogers (ROG), Amphenol (APH), and Corning (GLW). These companies are all part of the "electronic components" industry. Accelerant vs. Its Competitors Dolby Laboratories Littelfuse Vishay Intertechnology Rogers Amphenol Corning Dolby Laboratories (NYSE:DLB) and Accelerant (NYSE:ARX) are both mid-cap electronic components companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment. Is DLB or ARX more profitable? Dolby Laboratories has a net margin of 19.62% compared to Accelerant's net margin of 0.00%. Dolby Laboratories' return on equity of 11.52% beat Accelerant's return on equity.Company Net Margins Return on Equity Return on Assets Dolby Laboratories19.62% 11.52% 9.26% Accelerant N/A N/A N/A Which has stronger valuation & earnings, DLB or ARX? Dolby Laboratories has higher revenue and earnings than Accelerant. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDolby Laboratories$1.27B5.48$261.83M$2.7326.66AccelerantN/AN/AN/AN/AN/A Do institutionals & insiders believe in DLB or ARX? 58.6% of Dolby Laboratories shares are held by institutional investors. 38.4% of Dolby Laboratories shares are held by company insiders. Comparatively, 6.2% of Accelerant shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend DLB or ARX? Dolby Laboratories currently has a consensus target price of $103.00, indicating a potential upside of 41.52%. Given Dolby Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Dolby Laboratories is more favorable than Accelerant.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dolby Laboratories 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Accelerant 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to DLB or ARX? In the previous week, Dolby Laboratories had 9 more articles in the media than Accelerant. MarketBeat recorded 11 mentions for Dolby Laboratories and 2 mentions for Accelerant. Dolby Laboratories' average media sentiment score of 1.03 beat Accelerant's score of 0.00 indicating that Dolby Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dolby Laboratories 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Accelerant 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDolby Laboratories beats Accelerant on 11 of the 11 factors compared between the two stocks. Get Accelerant News Delivered to You Automatically Sign up to receive the latest news and ratings for ARX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ARX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARX vs. The Competition Export to ExcelMetricAccelerant Industry SectorNYSE ExchangeMarket Cap$6.23B$2.07B$2.07B$20.96BDividend YieldN/A13.69%13.66%3.58%P/E RatioN/A12.5012.2827.94Price / SalesN/A2,775,432.632,997,339.3556.15Price / CashN/A19.3557.5323.77Price / BookN/A3.243.095.26Net IncomeN/A-$440.16M-$456.46M$994.11M Accelerant Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARXAccelerantN/A$28.33flatN/AN/A$6.23BN/A0.00N/ADLBDolby Laboratories4.9311 of 5 stars$71.75-0.8%$102.33+42.6%+1.4%$6.89B$1.27B26.282,080Positive NewsEx-DividendAnalyst ForecastInsider TradeLFUSLittelfuse4.52 of 5 stars$247.33-0.7%$249.67+0.9%-3.9%$6.13B$2.19B51.5316,000News CoveragePositive NewsInsider TradeVSHVishay Intertechnology4.1491 of 5 stars$14.34+4.2%$20.50+43.0%-26.5%$1.94B$2.91B-29.2622,700Dividend AnnouncementROGRogers3.4326 of 5 stars$72.68+3.1%$85.00+17.0%-28.3%$1.32B$795.80M-20.573,200Trending NewsGap UpAPHAmphenol4.3753 of 5 stars$108.59-0.8%$104.92-3.4%+65.3%$132.53B$18.82B43.25125,000Positive NewsInsider TradeAnalyst RevisionGLWCorning4.0204 of 5 stars$64.64+1.0%$63.92-1.1%+62.5%$55.37B$14.21B68.7656,300Positive News Related Companies and Tools Related Companies DLB Competitors LFUS Competitors VSH Competitors ROG Competitors APH Competitors GLW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ARX) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerant Holdings Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access